News
.png)
Bugworks Research starts first human dose study to treat critical bacterial infections
Bugworks Research starts first human dose study to treat critical bacterial infectionsBengaluru : Bugworks Research announced that the first human dose was administered in a phase 1 clinical trial evaluating BWC0977: a next generation broad-spectrum, novel bacterial topoisomerase inhibitor (NBTI), supported by Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X).
Dr Reddy’s gets DCGI nod for single-shot Sputnik Light vaccine
Dr. Reddy’s Laboratories Ltd. on Monday announced that the Drugs Controller General of India (DCGI) has granted approval to the single-shot Sputnik Light vaccine for restricted use in emergency situation for COVID-19 in India.
DoP releases draft policy to catalyse R&D and innovation in pharma-MedTech sector
The draft policy aims to encourage R&D in Pharma-MedTech sector, and promoting innovation for India to become a leader in drug discovery and innovative medical devices through incubating an entrepreneurial environment. The department has invited comments from the stakeholders by November 6, 2021.
Exhibit in the 'India Pavilion' at BIO 2026
